Ancre

Toulouse CR2C launch sees the University Hospital Centre and the Pasteur Clinic join forces

2012 July

Against the background of increases in the number of cardiac patients and significant research developments, the Toulouse University Hospital and the Pasteur Clinic decided to pool their clinical research expertise in cardiology, beginning with interventional cardiology. This project gave birth to the creation of the Toulouse Clinical Research Centre for Cardiology, Toulouse CR2C.

 

Toulouse boasts two organisations, one private, the other public, which are recognised in France and across Europe for their expertise in cardiology. In fact, the Toulouse University Hospital Centre and the Pasteur Clinic rank first in France in the field of interventional cardiology, with 5000 coronary angioplasties performed and 300 percutaneous aortic valves fitted annually.

 

By creating the Toulouse Clinical Research Centre for Cardiology, the Toulouse University Hospital Centre and the Pasteur Clinic are aiming to become one of the first European referral centres for clinical research in interventional cardiology.

 

Such cooperation will serve to build upon and harmonise the clinical research activities of both institutions. The objective is to use this as a basis for setting up a research platform to enable new treatment and diagnostic strategies to be developed for eventual use on heart disease patients.

 

The Toulouse CR2C will enhance the appeal of Toulouse as a hub for this type of activity and will offer patients additional options for access to innovative treatment via research protocols.

 

The signing of the collaborative agreement took place on Tuesday 3 July 2012 at 11h30 at the Hôtel-Dieu, and was witnessed by the Regional Health Agency and manufacturing partners.